Initial Treatment with Sitagliptin as Monotherapy or Combination Therapy Improves Markers of β-Cell Function in Patients with Type 2 Diabetes

被引：0
|
作者：
Steinberg, Helmut
Engel, Samuel S.
Golm, Gregory T.
Alba, Maria
Langdon, Ronald B.
Kaufman, Keith D.
Goldstein, Barry J.
机构：
来源：
DIABETES | 2011年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2294-PO
引用
收藏
页码：A610 / A610
页数：1
相关论文
共 50 条
  • [1] Effect of initial combination therapy with sitagliptin and metformin on β-cell function in patients with type 2 diabetes
    Williams-Herman, D.
    Xu, L.
    Teng, R.
    Golm, G. T.
    Johnson, J.
    Davies, M. J.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (01): : 67 - 76
  • [2] Initial Combination Therapy with Sitagliptin and Pioglitazone Improves Glycemic Control and Measures of β-Cell Function Compared with Pioglitazone Alone in Patients with Type 2 Diabetes
    Yoon, Kun Ho
    Shockey, Gerald R.
    Teng, Rujun
    Golm, Gregory T.
    Thakkar, Payal R.
    Meehan, Alan G.
    Williams-Herman, Debora E.
    Kaufman, Keith D.
    Amatruda, John M.
    Steinberg, Helmut
    [J]. DIABETES, 2009, 58 : A139 - A140
  • [3] Substantial improvement in β-cell function with initial combination therapy of sitagliptin and metformin in patients with type 2 diabetes after 1 year of treatment
    Williams-Herman, Debora
    Xu, Lei
    Davies, Michael J.
    Stein, Peter P.
    Amatruda, John M.
    [J]. DIABETES, 2008, 57 : A161 - A161
  • [4] Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes
    Williams-Herman, D.
    Johnson, J.
    Teng, R.
    Golm, G.
    Kaufman, K. D.
    Goldstein, B. J.
    Amatruda, J. M.
    [J]. DIABETES OBESITY & METABOLISM, 2010, 12 (05): : 442 - 451
  • [5] Efficacy and safety of sitagliptin monotherapy and combination therapy in Japanese type 2 diabetes patients
    Kubota, Akira
    Maeda, Hajime
    Kanamori, Akira
    Matoba, Kiyokazu
    Jin, Yasuyuki
    Minagawa, Fuyuki
    Obana, Mitsuo
    Iemitsu, Kotaro
    Ito, Shogo
    Amamiya, Hikaru
    Kaneshiro, Mizuki
    Takai, Masahiko
    Kaneshige, Hideaki
    Hoshino, Kazuhiko
    Ishikawa, Masashi
    Minami, Nobuaki
    Takuma, Tetsuro
    Sasai, Nobuo
    Aoyagi, Sachio
    Kawata, Takehiro
    Mokubo, Atsuko
    Takeda, Hiroshi
    Honda, Shin
    Machimura, Hideo
    Motomiya, Tetsuya
    Waseda, Manabu
    Naka, Yoshikazu
    Tanaka, Yasushi
    Terauchi, Yasuo
    Matsuba, Ikuro
    [J]. JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 503 - 509
  • [6] Initial combination therapy with sitagliptin and pioglitazone improves glycaemic control and measures of beta cell function compared with pioglitazone alone in patients with type 2 diabetes
    Yoon, K.
    Shockey, G.
    Teng, R.
    Golm, G.
    Thakkar, P.
    Meehan, A.
    Williams-Herman, D.
    Kaufman, K.
    Amatruda, J.
    Steinberg, H.
    [J]. DIABETOLOGIA, 2009, 52 : S294 - S294
  • [7] Sitagliptin as combination therapy in the treatment of type 2 diabetes mellitus
    Miller, Shannon A.
    St Onge, Erin L.
    Accardi, J. Roger
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 23 - 30
  • [8] Sitagliptin and metformin combination therapy for the treatment of Type 2 diabetes
    Gallwitz, Baptist
    [J]. EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (04) : 543 - 556
  • [9] The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus
    Reasner, C.
    Olansky, L.
    Seck, T. L.
    Williams-Herman, D. E.
    Chen, M.
    Terranella, L.
    Johnson-Levonas, A. O.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETES OBESITY & METABOLISM, 2011, 13 (07): : 644 - 652
  • [10] Linagliptine monotherapy improves glycemic control and surrogate markers cell function in type 2 diabetes
    Del Prato, S. O.
    Barnett, A.
    Huismann, H.
    Neubacher, D.
    Woerle, H. -J.
    Tocque-Le -Gousse, E.
    Dugi, K. A.
    [J]. DIABETES & METABOLISM, 2011, 37 : A108 - A108
12345